LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $157 | -55.9% | 3,537 | -44.4% | 0.00% | -50.0% |
Q1 2024 | $356 | +1.4% | 6,359 | +9.0% | 0.00% | 0.0% |
Q4 2023 | $351 | +1850.0% | 5,832 | +2134.5% | 0.00% | – |
Q3 2023 | $18 | 0.0% | 261 | 0.0% | 0.00% | – |
Q2 2023 | $18 | +38.5% | 261 | 0.0% | 0.00% | – |
Q1 2023 | $13 | 0.0% | 261 | 0.0% | 0.00% | – |
Q4 2022 | $13 | -99.8% | 261 | +31.2% | 0.00% | – |
Q3 2022 | $8,000 | -27.3% | 199 | 0.0% | 0.00% | – |
Q2 2022 | $11,000 | -93.6% | 199 | -95.8% | 0.00% | -100.0% |
Q1 2022 | $172,000 | +36.5% | 4,716 | +74.9% | 0.00% | 0.0% |
Q4 2021 | $126,000 | +2000.0% | 2,696 | +2373.4% | 0.00% | – |
Q3 2021 | $6,000 | +200.0% | 109 | +172.5% | 0.00% | – |
Q2 2021 | $2,000 | +100.0% | 40 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 40 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 40 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |